Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A Multi-center Phase 1/2a Study of Narazaciclib (ON 123300) in Combination with Letrozole as Second- or Third-line Therapy for the Treatment of Recurrent Metastatic Low-grade Endometrioid Endometrial Cancer (19-02)

  • Details

ClinicalTrials.gov ID: NCT05705505
Diagnosis Type: Endometrial Cancer
USOR Number: 23007

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Arizona Oncology - Goodyear

Harbinger Health Collection of Blood and Tissue Samples from Cancer andNon-Cancer Subjects for Validation of a Novel Blood-Based Multi-CancerScreening Test (HH-PRT-0001)

  • Details

ClinicalTrials.gov ID: NCT05435066
Diagnosis Type: Thyroid Cancer
USOR Number: 22311

  • Practice Details

13555 W. McDowell Rd.
Suite 105
Goodyear, AZ 85395
P: (623) 469-4222

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Goodyear

Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)

  • Details

ClinicalTrials.gov ID: NCT05885698
Diagnosis Type: Lung Cancer
USOR Number: 22285

  • Practice Details

13555 W. McDowell Rd.
Suite 105
Goodyear, AZ 85395
P: (623) 469-4222

More Details View Practice Page

Lymphomas

Clinical Trial at: Arizona Oncology - Tucson

First-in-Human Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of the BTK Degrader, ABBV-101, in Participants with B-cell Malignancies (M23-647)

  • Details

ClinicalTrials.gov ID: NCT05753501
Diagnosis Type: Lymphomas
USOR Number: 22249

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A PHASE II, SINGLE-ARM STUDY OF GIREDESTRANT IN PATIENTS WITH GRADE 1 ENDOMETRIAL CANCER (CO44195)

  • Details

ClinicalTrials.gov ID: NCT05634499
Diagnosis Type: Endometrial Cancer
USOR Number: 22200

  • Practice Details

1845 W. Orange Grove, Bldg. 2
Tucson, AZ 85704
P: (520) 624-7445

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A PHASE II, SINGLE-ARM STUDY OF GIREDESTRANT IN PATIENTS WITH GRADE 1 ENDOMETRIAL CANCER (CO44195)

  • Details

ClinicalTrials.gov ID: NCT05634499
Diagnosis Type: Endometrial Cancer
USOR Number: 22200

  • Practice Details

2070 W. Rudasill Rd., #130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Arizona Oncology - Tucson

A PHASE II, SINGLE-ARM STUDY OF GIREDESTRANT IN PATIENTS WITH GRADE 1 ENDOMETRIAL CANCER (CO44195)

  • Details

ClinicalTrials.gov ID: NCT05634499
Diagnosis Type: Endometrial Cancer
USOR Number: 22200

  • Practice Details

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Tucson

(FURMO-004) A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Furmonertinib Compared to Platinum-Based Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

  • Details

ClinicalTrials.gov ID: NCT05607550
Diagnosis Type: Lung Cancer
USOR Number: 22198

  • Practice Details

1845 W. Orange Grove, Bldg. 2
Tucson, AZ 85704
P: (520) 624-7445

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Tucson

(FURMO-004) A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Furmonertinib Compared to Platinum-Based Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

  • Details

ClinicalTrials.gov ID: NCT05607550
Diagnosis Type: Lung Cancer
USOR Number: 22198

  • Practice Details

2070 W. Rudasill Rd., #130
Tucson, AZ 85704
P: (520) 797-4468

More Details View Practice Page

Lung Cancer

Clinical Trial at: Arizona Oncology - Tucson

(FURMO-004) A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Furmonertinib Compared to Platinum-Based Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

  • Details

ClinicalTrials.gov ID: NCT05607550
Diagnosis Type: Lung Cancer
USOR Number: 22198

  • Practice Details

1620 W. St. Mary's Rd.
Tucson, AZ 85745
P: (520) 624-7445

More Details View Practice Page
1 2 3 13